Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
SEC
- S-1/A IPO registration
- 1.1 Underwriting agreement
- 2.1 Plan of acquisition, reorganization, arrangement, liquidation or succession
- 3.1 Articles of incorporation
- 3.1.1 EX-3.1.1
- 3.1.2 EX-3.1.2
- 3.1.3 EX-3.1.3
- 3.1.4 EX-3.1.4
- 3.2 Bylaws
- 4.1 Instruments defining the rights of security holders, including indentures
- 4.2 Instruments defining the rights of security holders, including indentures
- 4.3 Instruments defining the rights of security holders, including indentures
- 4.5 Instruments defining the rights of security holders, including indentures
- 4.6 Instruments defining the rights of security holders, including indentures
- 5.1 Legality opinion
- 10.1 Material contracts
- 10.2 Material contracts
- 10.3 Material contracts
- 10.4 Material contracts
- 10.5 Material contracts
- 10.6 Material contracts
- 10.7 Material contracts
- 10.8 Material contracts
- 10.9 Material contracts
- 10.11 Material contracts
- 10.12 Material contracts
- 10.13 Material contracts
- 21.1 Subsidiaries of the registrant
- 23.2 Consent of experts and counsel
- Download Excel data file
- View Excel data file
Associated filings
- 5 Oct 20 424B4 Prospectus supplement with pricing info
- 2 Oct 20 EFFECT Notice of effectiveness
- 30 Sep 20 S-1/A IPO registration (amended)
- 25 Sep 20 RW WD Withdrawal of registration withdrawal request
- 25 Sep 20 RW Registration withdrawal request
-
17 Sep 20 S-1/A IPO registration (amended)
- 17 Jul 20 S-1/A IPO registration (amended)
- 13 Dec 19 S-1 IPO registration
PCSA similar filings
Filing view
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We hereby consent to the inclusion in this Amendment No. 2 to Registration Statement No. 333-235511 on Form S-1 and the related prospectus of our report dated March 6, 2020, of our audit of the consolidated financial statements of Processa Pharmaceuticals, Inc. as of and for the years ended December 31, 2019 and 2018. We also consent to the reference to our firm under the caption “Experts” in such Registration Statement.
/s/ BD & Co.
Owings Mills, MD
September 16, 2020